On February 8, 2021 Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, reported that Derek Maetzold, president and chief executive officer, is scheduled to present a company overview at the following upcoming investor conferences (Press release, Castle Biosciences, FEB 8, 2021, View Source [SID1234574744]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Feb. 17, 2021, at 10:30 a.m. Eastern time.
10th Annual SVB Leerink Global Healthcare Conference on Feb. 24, 2021, at 10:00 a.m. Eastern time.
Live audio webcasts of the company’s presentations will be available by visiting Castle Biosciences’ website at View Source Replays of the webcasts will be available for two weeks following the conclusion of the live broadcasts.